Evidence map›Paper›PMID 37681883›Full record

ReviewCells2023

T Cells in Atherosclerosis: Key Players in the Pathogenesis of Vascular Disease.

Hannah Hinkley, Daniel A Counts, Elizabeth VonCanon, Michael Lacy

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. CD8Nature reviews. Cardiology · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Single-Cell RNA Sequencing Reveals Granzyme KJournal of the American Heart Association · 2025
    Article
  16. Anti-Atherogenic Mechanisms and Therapies.Current atherosclerosis reports · 2025
    Review
  17. Article
  18. Review
  19. miRNAs and T cell-mediated Immune Response in Disease.The Yale journal of biology and medicine · 2025
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Hannah HinkleyDepartment of Medical Laboratory Sciences, Virginia Commonwealth University, Richmond, VA 23298, USA.
Daniel A CountsDepartment of Medical Laboratory Sciences, Virginia Commonwealth University, Richmond, VA 23298, USA.
Elizabeth VonCanonDepartment of Medical Laboratory Sciences, Virginia Commonwealth University, Richmond, VA 23298, USA.
Michael LacyDepartment of Medical Laboratory Sciences, Virginia Commonwealth University, Richmond, VA 23298, USA.ORCID 0000-0001-5944-582X
Virginia Commonwealth University Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Atherosclerosis is a chronic inflammatory disease characterized by the accumulation of lipid-rich plaques within arterial walls. T cells play a pivotal role in the pathogenesis of atherosclerosis in which they help orchestrate immune responses and contribute to plaque development and instability. Here, we discuss the recognition of atherosclerosis-related antigens that may trigger T cell activation together with additional signaling from co-stimulatory molecules and lesional cytokines. Although few studies have indicated candidates for the antigen specificity of T cells in atherosclerosis, further research is needed. Furthermore, we describe the pro-atherogenic and atheroprotective roles of diverse subsets of T cells such as CD4

Indexed as

AtherosclerosisCardiovascular DiseasesAntibody SpecificityArteriesHumansT-Lymphocytesatherosclerosiscardiovascular diseaseinflammationT cells

Identifiers

PMID37681883
PMCPMC10486666
OpenAlexW4386222257

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.